Skip to main content
Susan (Pillsbury) Knox, MD, Radiation Oncology, Palo Alto, CA, Lucile Packard Children's Hospital Stanford

SusanJane(Pillsbury)KnoxMDPh.D.

Radiation Oncology Palo Alto, CA

Academic

Dr. Knox is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Knox's full profile

Already have an account?

Education & Training

  • Stanford Health Care-Sponsored Stanford University
    Stanford Health Care-Sponsored Stanford UniversityResidency, Radiation Oncology, 1986 - 1990
  • University of California Davis Health
    University of California Davis HealthInternship, Internal Medicine, 1985 - 1986
  • Stanford University School of Medicine
    Stanford University School of MedicineClass of 1985

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1986 - 2024

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Dose-Dependent Nuclear Delivery and Transcriptional Repression with a Cell-Penetrant MeCP2
    Dose-Dependent Nuclear Delivery and Transcriptional Repression with a Cell-Penetrant MeCP2February 22nd, 2023
  • Stanford Medical Students Celebrate Match Day Virtually
    Stanford Medical Students Celebrate Match Day VirtuallyMarch 22nd, 2021
  • Eighty-Five Medical Students Meet Their Matches
    Eighty-Five Medical Students Meet Their MatchesMarch 15th, 2019

Grant Support

  • Protocol Review And Monitoring System (PRMS)National Cancer Institute2007–2009
  • Clinical Trial: Phase II Study Of Bexxar In Relapsed/Refractory DlclNational Center For Research Resources2008
  • Clinical Trial: Bexxar Combined With External Beam Radiation Therapy For PatientNational Center For Research Resources2008
  • Phase II Study Of Bexxar In Relapsed/Refractory DlclNational Center For Research Resources2006–2007
  • Anti B1 Antibody For Nonhodgkins LymphomaNational Center For Research Resources2000–2001
  • Phase II Multicenter Trial Of 90 Yttrium DOTA Biotin In Subjects W/ CancerNational Center For Research Resources1999–2000
  • Iodine Anti B1 Murine Radioimmunotherapy For Chemotherapy LymphomaNational Center For Research Resources1999–2000
  • Anti-B1 (MURINE) In Chemotherapy-Refractory Low Grade Nonhodgkin'S LymphomaNational Center For Research Resources1997–2000
  • Study Of 90 Yttrium/Dota/Biotin Localization In Advanced CancerNational Center For Research Resources1996–2000
  • Pivotal Phase II/III Of Murine Radioimmunotherapy For LymphomasNational Center For Research Resources1998–1999
  • BCL-2, Na+/K+ Atpase And Radiation Induced ApoptosisNational Cancer Institute1996–1998
  • Radiobiology Of Low Dose Rate RadioimmunotherapyNational Cancer Institute1994–1997
  • Intravenously Administered 90y-Cyi-356 In Metastatic Prostate CancerNational Center For Research Resources1996
  • B Cell Lymphoma With 90y-Labeled B1 (Anti-Cd20) Monoclonal AntibodyNational Center For Research Resources1996
  • Radiobiology Of Low-Dose Rate RadioimmunotherapyNational Cancer Institute1993

Hospital Affiliations